Assessment of the Expression of Candidate Human Plasma Membrane Phospholipid Scramblase in Scott Syndrome Cells

 

^* CRTH-CHRU, Nantes, France

• References

• 1 Weiss HJ. Scott syndrome: a disorder of platelet procoagulant activity. Semin Hematol 1994; 31: 312-9.
• 2 Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
• 3 Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996; 87: 1409-15.
• 4 Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase. J Biol Chem 1997; 272: 18240-4.
• 5 Zhou Q, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood 1998; 92: 1707-12.
• 6 Zhao J, Zhou Q, Wiedmer T, Sims PJ. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem 1998; 273: 6603-6.
• 7 Zhou Q, Sims PJ, Wiedmer T. Identity of a conserved motif phospholipid scramblase that is required for Ca²⁺-accelerated transbilayer movement of membrane phospholipids. Biochemistry 1998; 37: 2356-60.
• 8 Kasukabe T, Kobayashi H, Kaneko Y, Okabe-Kado J, Honma Y. Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesiS-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene. Biochem Biophys Res Commun 1998; 249: 449-55.